Page last updated: 2024-10-29

avapro and Adenocarcinoma Of Kidney

avapro has been researched along with Adenocarcinoma Of Kidney in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamias, A1
Manios, E1
Karadimou, A1
Michas, F1
Lainakis, G1
Constantinidis, C1
Deliveliotis, C1
Zakopoulos, N1
Dimopoulos, MA1

Other Studies

1 other study available for avapro and Adenocarcinoma Of Kidney

ArticleYear
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer.
    European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Benzopyr

2011